Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b

Stanley Calderwood(Children's Hospital of Philadelphia), Joanne Kurtzberg(Duke University), Steven D. Douglas(Purdue University West Lafayette), Martha Rolland(Children's Hospital of Philadelphia), Kim Smith‐Whitley(Children's Hospital of Philadelphia), Laurie E. Kilpatrick(Temple University), Melvin H. Freedman(Hospital for Sick Children)

Blood

January 15, 2001

Cited by 86

|Journal of Allergy and Clinical Immunology|2003|828

|British Journal of Pharmacology|2021|488

|British Journal of Pharmacology|2023|390

|The Journal of Immunology|1997|386

|American Journal of Psychiatry|2002|377

Related Papers